THE ATTENDANCE OF THE THIRD SCREENING ROUND (2006-2007) OF THE HUNGARIAN ORGANIZED, NATIONWIDE BREAST CANCER SCREENING PROGRAM

Author(s)

Boncz I*1;Dobrossy L2;Péntek Z3;Kovács A2;Budai A2;Vajda R1, Sebestyén A4 1University of Pécs, Pécs, Hungary, 2National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary, 3MaMMa Healthcare Ltd, Budapest, Hungary, 4National Health Insurance Fund Administration, Pécs, Hungary

OBJECTIVES: Organized, nationwide screening for breast cancer with mammography started in Hungary in January 2002. Women in the age group 45-65 years are the target population and 2 years screening interval is applied. The aim of this study is to analyze the attendance rate of the 3rd screening round (2006-2007). METHODS: The data derive from the financial database of the National Health Insurance Fund Administration (NHIFA) covering the period of 2006-2007. We calculated two attendance indicators. The up-take of the program means the percentage of women aged 45-65 who, having been sent an invitation for screening, attend a screening unit and undergo mammography in response to that invitation. We defined coverage as the ratio of women in the age group 45-65 years having either a screening mammography or a diagnostic mammography. RESULTS: In 2006-2007 there were 453142 screening mammography cases and 1248183 diagnostic mammography examinations in Hungary. We found 41.7 % and 52.5 % up-take in 2006 and 2007 respectively; and 46.3 % combined rate for 2006/2007. The screening coverage was 29.2 % and the diagnostic coverage was 21.6 %, while the total coverage (screening and diagnostic) was 49.3 %. CONCLUSIONS: The attendance of the Hungarian organized breast cancer screening program – compared to the previous period before the implementation of the organized screening program – is promising, although to achieve the expected results in mortality decrease a further improvement of both the uptake and coverage is necessary.

Conference/Value in Health Info

2013-05, ISPOR 2013, New Orleans, LA, USA

Value in Health, Vol. 16, No. 3 (May 2013)

Code

PCN10

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×